Compound of Interest - "Hit" Identified from a High-Throughput Screening Study

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Australian bats are at risk from the deadly fungal disease White Nose Syndrome (WNS), which is expected...
Many people will experience a decline in vision at some point in their life. For many people, this may be...
Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve...
0 comments